glioblastoma Apr 19, 2022 Break Through Cancer Awards $50M in Grants for Collaborative Projects in Ovarian, Pancreatic, Brain Cancers Apr 14, 2022 Mustang Bio to Study CAR T-Cell, Oncolytic Virus Combination for Recurrent Brain Cancer Patients Apr 12, 2022 Chimeric Partners With WuXi Advanced Therapies to Develop and Manufacture CAR T Therapies Jan 12, 2022 Grant Funding Supports Research on Kintara's VAL-083 in GBM Models Jan 11, 2022 Black Diamond Therapeutics IND for BDTX-1535 Cleared by FDA Jan 6, 2022 Penn Spinout Verismo Therapeutics Trying to Skirt T-Cell Exhaustion in Cell Therapy for Solid Cancer Premium Nov 15, 2021 MimiVax to Begin Phase II Study of Immunotherapy Vaccine in Glioblastoma Oct 29, 2021 Canbridge Pharmaceuticals Studying CAN008 in Phase II Glioblastoma Multiforme Trial in China Oct 12, 2021 MIT Spinoff Travera Looks to Validate Cell Mass as Broadly Predictive Cancer Biomarker Premium May 20, 2021 Mustang Bio Initiates CAR T-Cell Therapy in Phase I Brain Tumor Trial Mar 22, 2021 Berg Advances BPM31510, Applies AI Platform to Biomarker Search in Phase II Brain Cancer Trial Premium Jan 11, 2021 Glioblastoma Transcriptomes Point to Mitochondrial Subtype, Potential Treatment Strategies Jan 8, 2021 Denovo Begins Phase III Glioblastoma Trial of Enzastaurin Jan 7, 2021 Kazia Therapeutics, Kintara Therapeutics Begin Trials in Glioblastoma Platform Study Dec 23, 2020 Bristol Myers Unblinds Trial After Opdivo, Chemoradiation Fail to Extend Survival in Glioblastoma Dec 22, 2020 Mustang Bio, City of Hope Initiate Clinical Trial of CAR T-cell Therapy in Brain Cancer Patients Nov 19, 2020 Exceptional Responders Cancer Study Points to Possible Treatment Targets Premium Oct 26, 2020 Turning Point Therapeutics Reports Early TPX-0022 Data in MET-Altered Tumors Oct 19, 2020 Kazia Therapeutics' Paxalisib to be Evaluated in Glioblastoma Study Aug 7, 2020 UCSF Glioblastoma Projects Using Molecular Data to Inform Subtypes, Match Patients to Treatments Premium Load More Breaking News Dragonfly Therapeutics Begins Phase II Trial of HER2-Targeted NK-Cell Engager Touchlight to Provide DNA Vector for Odimma Therapeutics' Personalized Neoantigen Vaccine Trial FDA Approves Thermo Fisher HLA Typing Test as CDx for Immunocore Uveal Melanoma Therapy Caris Life Sciences, Hummingbird Bioscience Partner on Anti-HER3 Therapy Advancement Akeso, Summit Therapeutics Ink $5B Licensing Deal for PD-1/VEGF Bispecific Antibody Bluestar Genomics to Study Pancreatic Cancer Early Detection Test in Type 2 Diabetes Patients
